162 related articles for article (PubMed ID: 12747011)
41. Genistein contributes to cell cycle progression and regulates oxidative stress in primary culture of osteoblasts along with osteoclasts attenuation.
Siddiqui S; Mahdi AA; Arshad M
BMC Complement Med Ther; 2020 Sep; 20(1):277. PubMed ID: 32917180
[TBL] [Abstract][Full Text] [Related]
42. Employing different types of phytoestrogens improve bone mineralization in bisphenol A stimulated osteoblast.
Thent ZC; Froemming GRA; Ismail ABM; Fuad SBSA; Muid S
Life Sci; 2018 Oct; 210():214-223. PubMed ID: 30145154
[TBL] [Abstract][Full Text] [Related]
43. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.
Xu SZ; Zhong W; Ghavideldarestani M; Saurabh R; Lindow SW; Atkin SL
Free Radic Biol Med; 2009 Jul; 47(2):167-75. PubMed ID: 19393315
[TBL] [Abstract][Full Text] [Related]
44. [Effect of isoflavones in regulating the transcription of target genes through estrogen receptors].
Meng QS; Zhu XY; Tang XL; Ma B; Ni X
Zhong Xi Yi Jie He Xue Bao; 2007 Sep; 5(5):577-80. PubMed ID: 17854564
[TBL] [Abstract][Full Text] [Related]
45. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
46. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats.
Yokose S; Ishizuya T; Ikeda T; Nakamura T; Tsurukami H; Kawasaki K; Suda T; Yoshiki S; Yamaguchi A
Endocrinology; 1996 Feb; 137(2):469-78. PubMed ID: 8593791
[TBL] [Abstract][Full Text] [Related]
47. Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.
Karamsetty MR; Klinger JR; Hill NS
J Pharmacol Exp Ther; 2001 Jun; 297(3):968-74. PubMed ID: 11356918
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778.
Notoya K; Nagai H; Oda T; Gotoh M; Hoshino T; Muranishi H; Taketomi S; Sohda T; Makino H
J Pharmacol Exp Ther; 1999 Sep; 290(3):1054-64. PubMed ID: 10454478
[TBL] [Abstract][Full Text] [Related]
49. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
Froyen EB; Steinberg FM
J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
[TBL] [Abstract][Full Text] [Related]
50. Effect of cell therapy with allogeneic osteoblasts on bone repair of rat calvaria defects.
Souza ATP; Freitas GP; Lopes HB; Ferraz EP; Oliveira FS; Beloti MM; Rosa AL
Cytotherapy; 2018 Oct; 20(10):1267-1277. PubMed ID: 30196010
[TBL] [Abstract][Full Text] [Related]
51. Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure.
Adams SM; Aksenova MV; Aksenov MY; Mactutus CF; Booze RM
PLoS One; 2012; 7(5):e37540. PubMed ID: 22629415
[TBL] [Abstract][Full Text] [Related]
52. Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK, and Wnt/β-catenin pathways.
Wang PP; Zhu XF; Yang L; Liang H; Feng SW; Zhang RH
J Asian Nat Prod Res; 2012; 14(9):897-905. PubMed ID: 22917468
[TBL] [Abstract][Full Text] [Related]
53. Effects of phytoestrogens genistein and daidzein on progesterone and estrogen (estradiol) production of human term trophoblast cells in vitro.
Richter DU; Mylonas I; Toth B; Scholz C; Briese V; Friese K; Jeschke U
Gynecol Endocrinol; 2009 Jan; 25(1):32-8. PubMed ID: 19165661
[TBL] [Abstract][Full Text] [Related]
54. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations.
Zhang Y; Song TT; Cunnick JE; Murphy PA; Hendrich S
J Nutr; 1999 Feb; 129(2):399-405. PubMed ID: 10024618
[TBL] [Abstract][Full Text] [Related]
55. The proliferation, differentiation, and mineralization effects of puerarin on osteoblasts in vitro.
Wang C; Meng MX; Tang XL; Chen KM; Zhang L; Liu WN; Zhao YY
Chin J Nat Med; 2014 Jun; 12(6):436-42. PubMed ID: 24969524
[TBL] [Abstract][Full Text] [Related]
56. Glucose-induced inhibition of in vitro bone mineralization.
Balint E; Szabo P; Marshall CF; Sprague SM
Bone; 2001 Jan; 28(1):21-8. PubMed ID: 11165939
[TBL] [Abstract][Full Text] [Related]
57. Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro.
Karieb S; Fox SW
Br J Nutr; 2012 Nov; 108(10):1736-45. PubMed ID: 22289672
[TBL] [Abstract][Full Text] [Related]
58. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis.
Dang ZC; van Bezooijen RL; Karperien M; Papapoulos SE; Löwik CW
J Bone Miner Res; 2002 Mar; 17(3):394-405. PubMed ID: 11878304
[TBL] [Abstract][Full Text] [Related]
59. Effects of TGF-β1 on mineralization mediated by rat calvaria-derived osteogenic cells.
Donato TA; Martinez EF; Arana-Chavez VE
Microsc Res Tech; 2016 Dec; 79(12):1139-1146. PubMed ID: 27557631
[TBL] [Abstract][Full Text] [Related]
60. Isoflavone genistein and daidzein up-regulate LPS-induced inducible nitric oxide synthase activity through estrogen receptor pathway in RAW264.7 cells.
Nakaya M; Tachibana H; Yamada K
Biochem Pharmacol; 2005 Dec; 71(1-2):108-14. PubMed ID: 16271352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
